Details of the Drug Reposition

General Information of This Drug (ID: DM2UP6Z)

Drug Name
ARO-AAT   DM2UP6Z
Drug Type
Small interfering RNA

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Alopecia DIS37HU4 ED70 Phase 2 [1]
------------------------------------------------------------------------------------
1 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Alpha-1 antitrypsin deficiency DISQKEHW 5C5A Phase 1 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03946449) Study of ARO-AAT in Patients With Alpha-1 Antitrypsin Deficiency Associated Liver Disease (AATD). U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT03362242) Study of ARO-AAT in Normal Adult Volunteers. U.S. National Institutes of Health.